Japan, Nov. 11 -- AUSPEX PHARMACEUTICALS INC has got intellectual property rights for 'OSMOTIC DOSAGE FORMS COMPRISING DEUTETRABENAZINE AND METHODS OF USE THEREOF.' Other related details are as follows:
Application Number: JP,2024-001864
Category (FI): A61K47/36,A61K31/4745,A61P25/16,A61P25/14,A61P25/00,A61K9/22,A61K9/20,A61K47/42,A61K47/38,A61K47/32,A61K47/22,A61K47/12,A61K47/10,A61K47/02
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Jan. 10, 2024
Publication Date: April 26, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
